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In 2007 the International Diabetes Federation (IDF) proposed single blood pressure (BP) cutpoints (systolic:
≥130 mm Hg and diastolic: ≥85 mm Hg) for the diagnosis of high blood pressure (HBP) in adolescents. Before
this proposal, HBP had been defined as BP at or above the 95th percentile for age, sex, and height percentile (ref-
erence standard). In this study, we evaluated the risk for misclassification when using the IDF single-cutpoints cri-
teria. We first applied the IDF criteria to a reconstructed population with the same age, sex, and height distribution
as the population used to develop the reference standard. The proposed single cutpoints corresponded to percen-
tiles from the 81.6th to 99.9th for systolic BP and from the 92.9th to 98.9th for diastolic BP in the reconstructed
population. Using IDF criteria, there were high false-negative fractions for both systolic and diastolic BP (from 54%
to 93%) in 10- to 12-year-olds and a false-positive fraction up to 35% in older subjects. We then applied the IDF
criteria to 1,162 overweight/obese adolescents recruited during 1998–2000 from pediatric clinical centers in
Milano, Varese, and Modena in Italy and in Zaragoza, Spain. Overall false-negative and false-positive fractions
were 22% and 2%, respectively; negative predictive values were especially low for 10- to 12-year-old sub-
jects. The use of IDF’s single cutpoints carries a high risk of misclassification, mostly due to false negatives in
younger subjects. The effort to simplify diagnosis could be overcome by the risk of undiagnosed HBP.
adolescence; hypertension; metabolic syndrome; obesity; overweight
Abbreviations: CDC, Centers for Disease Control and Prevention; DBP, diastolic blood pressure; FNF, false-negative fraction;
FPF, false-positive fraction; HBP, high blood pressure; IDF, International Diabetes Federation; MS, metabolic syndrome;
NHBPEP, National High Blood Pressure Education Program; NPV, negative predictive value; PPV, positive predictive value;
SBP, systolic blood pressure.
Metabolic syndrome (MS) is a condition whose existence
and definition in adults, in whom it was first characterized,
are undergoing a heated debate (1–4). In children and ado-
lescents there is no consensus on how MS should be diag-
nosed (5). Controversies are related mainly to 2 diverging
approaches: one adapting the definition of MS from adults
(6–8) and the other based on a distributional approach,
which is typical in populations in which individuals are
still growing (9, 10).
In 2007, the International Diabetes Federation (IDF) pro-
posed a set of age-related criteria for the diagnosis of MS in
the pediatric population (11, 12). For adolescents (i.e., 10-
to 16-year-olds), MS can be diagnosed by a finding of
abdominal obesity and the presence of at least 2 of the follow-
ing conditions: high blood pressure (HBP), hypertriglyceride-
mia, hyperglycemia, or reduced high-density lipoprotein
cholesterolemia. According to the IDF criteria, the diagnosis
of HBP is based on 2 single cutpoints: ≥130 mm Hg for sys-
tolic blood pressure (SBP) and ≥85 mm Hg for diastolic
blood pressure (DBP), thus using the existing criteria for
MS diagnosis in adults. The use of these single cutpoints
is recommended regardless of other characteristics, such
as age, sex, or height (12). These criteria were used in
subsequent literature (13, 14).
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Before the IDF proposal, the established criteria used to
diagnose HBP in the pediatric population were developed
by the National High Blood Pressure Education Program
(NHBPEP) Working Group on High Blood Pressure in
Children and Adolescents. These criteria were defined using
the distribution, in a large US population, of blood pressure
values calculated specifically for a child’s sex, age, and
height percentile, to account for the dependence of BP on
body size (15). The condition of systolic HBP is defined by
SBP at or above the 95th percentile of the reference distribu-
tion for the sex, age, and height percentile of the patient.
Diastolic HBP is defined correspondingly. HBP is defined
as elevated measurements of systolic and/or diastolic blood
pressure. The 95th percentiles of SBP and DBP will be
referred to as sex-age-height cutpoints hereafter.
The rationale for a classification accounting for age, sex,
and height is that these factors influence SBP and DBP in
adolescents (16), and the use of 95th percentiles enables
practitioners to identify a fixed 5% fraction of subjects with
systolic HBP. The same is true for diastolic HBP.
The aim of the present study was to evaluate the possi-
bility of classification errors from using the simplified single-
cutpoints IDF criteria in the diagnosis of HBP in adolescents,
comparing IDF criteria with the NHBPEP sex-age-height cri-
teria that are considered to be the reference standard for
the definition of HBP. Although the NHBPEP criteria cannot
be considered the reference standard to predict organ dam-
age in adults—there are no follow-up studies linking those
conditions—NHBPEP-defined hypertension has been related
to early organ damage in several studies (17–20).
We evaluated classification errors made when using the
single-cutpoint IDF criteria in the diagnosis of HBP in 2
different settings. First, we considered a reconstructed popu-
lation of adolescents aged 10–16 years with SBP and DBP
distributions that mimicked the population in which the
NHBPEP criteria were derived (15). Second, we considered
a large sample of white children followed in pediatric clinics
and at increased risk of MS due to overweight or obesity
conditions.
METHODS
IDF and NHBPEP criteria
The contrast for SBP and DBP between the IDF’s simpli-
fied single-cutpoint criteria and the sex-age-height NHBPEP
criteria for the diagnosis of HBP is shown in Figure 1, sepa-
rately for boys and girls. The piecewise linear curves repre-
sent the NHBPEP cutpoints for specific age classes for the
range of height percentiles. These cutpoints were obtained
from the NHBPEP Working Group on High Blood Pressure
in Children and Adolescents (15), defining the criteria from
the original population as the 95th percentile in the BP
distribution according to sex, age, and height percentile. In
each panel, a dashed horizontal line was added to represent
the IDF single cutpoints, which were defined regardless of
sex, age, and height percentile. The IDF proposed cutpoint of
130 mm Hg corresponds to percentiles of the NHBPEP SBP
distributions ranging from a minimum of 81.6th (for male
16-year-olds at the 95th percentile for height) to a maximum
of 99.9th (for male 10-year-olds at the 5th percentile for
height). The proposed cutpoint of 85 mm Hg corresponds to
percentiles of the NHBPEP DBP distributions ranging from
a minimum of 92.9th (for male 16-year-olds at the 95th per-
centile for height) to a maximum of 98.9th (for male or female
10-year-olds at the 5th percentile for height).
Reconstructed general population
The distribution of SBP and DBP in the general population
of adolescents in which the NHBPEP criteria were developed,
was reconstructed, restricting ages to 10–16 years, as follows:
The mean values of SBP and DBP were obtained using the
parameters of the nonlinear regression models (based on sex,
age, and height) published in 2004 by the NHBPEP Working
Group on High Blood Pressure in Children and Adolescents
(15). The standard deviation was then derived from the pub-
lished table of percentiles, assuming Gaussian distribution
of SBP and DBP (15). The distributions of SBP and DBP
for each sex, age class, and height percentile were then
derived by incorporating the obtained means and standard
deviations into the corresponding parameters of the
Gaussian distribution. Overall, for each type of blood pres-
sure, 84 distributions were reconstructed (6 age classes and
7 height percentiles for each sex).
In Web Figure 1A (available at http://aje.oxfordjournals.
org/), the distribution of SBP is represented for girls with
heights at the 10th (continuous line) and 90th (dashed line)
percentiles. Increasing height percentile shifts the SBP dis-
tribution to the right. This justifies the increasing values of
the NHBPEP sex-age-height cutpoints with increasing height
percentile within each age class (Figure 1). This graph
also illustrates that, using the NHBPEP criteria, the proportion
of adolescents considered to have HBP is constant regardless
of height percentile (the filled and line-shaded areas are both
equal to 5%), and the same is true for sex and age. In con-
trast, using a single IDF cutpoint, the proportion of ado-
lescents diagnosed with HBP falls with decreasing height
percentiles—that is, the solid filled area to the right of the
gray line is smaller (1.5%) than the corresponding line-shaded
area (4.2%). Web Figure 1B illustrates that the IDF cutpoint
can also be lower than the NHBPEP cutpoint when the distri-
bution has a higher mean, as it does among 15-year-old boys.
Overweight/obese adolescent sample
A group of white, overweight/obese subjects, aged 10–
16 years, was also considered. This sample will be referred
to hereafter as the clinical sample. The 1,162 children (551
(47.4%) girls) were recruited at 4 pediatric clinical centers
for the care of childhood obesity: 627 subjects from Varese
(Italy), 244 from Modena (Italy), 177 from Milano (Italy),
and 114 from Zaragoza (Spain). Exclusion criteria were
endocrine obesity, genetic syndromes, psychiatric disorders,
and the presence of any other chronic disease or drug treat-
ment. The local ethical committee approved data collec-
tion at each participating center.
Measurements of weight, height, and blood pressure were
taken according to the Anthropometric Standardization Refer-
ence Manual (21). Body mass index was calculated as weight
Am J Epidemiol. 2017;185(4):295–303
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(kg)/height (m)2. We used US Centers for Disease Control
and Prevention (CDC) reference data and the LMS (lambda-
mu-sigma) method to calculate z scores for weight, height, and
body mass index (22). CDC growth charts were used because
the NHBPEP reference values for SBP and DBP are based on
CDC height values. Children were defined as overweight if
their body mass index was ≥85th and <95th percentile for age
and sex and as obese if their body mass index was ≥95th per-
centile for age and sex. Pubertal status was defined by a
physician according to Tanner and Whitehouse (23), and
the subjects were classified in stages from 1 to 5.
Blood pressure was measured using a mercury sphygmo-
manometer, with the appropriate cuff for the upper-arm size
(15). SBP was defined by the onset of the first Korotkoff
sound, and DBP was indicated by the fifth Korotkoff sound.
Blood pressure measurements were performed while chil-
dren were sitting with the cubital fossa supported at heart
level, after at least 5 minutes of rest. We considered 3 mea-
surements per subject, collected on different days.
Children were classified for both systolic and diastolic
HBP using the reference-standard NHBPEP criteria if the
means of 3 measurements were ≥95th percentile for age,
sex, and height percentile (15); age and height were approxi-
mated to the nearest value. Subjects were also classified ac-
cording to the simplified IDF criteria for systolic and diastolic
HBP if the means of 3 measurements were ≥130 mm Hg for
SBP or ≥85 mm Hg for DBP (11).
STATISTICAL METHODS
The classification errors, when using the simplified single-
cutpoint IDF criteria instead of the reference standard
NHBPEP criteria, were first analyzed in terms of the false-
positive fraction (FPF) and the false-negative fraction (FNF)
of the identification of both systolic and diastolic HBP.
FPF was the probability of classifying a participant as hav-
ing HBP according to the IDF criteria when that participant
did not have HBP according to the NHBPEP definition. FNF
was the probability of classifying a participant as not having
HBP according to the IDF criteria when that participant did
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Figure 1. Cutoff values for diagnosis of high systolic and diastolic blood pressure (BP). A) Systolic BP in girls; B) systolic BP in boys; C) dia-
stolic BP in girls; and D) diastolic BP in boys. The curves represent the standards according to the criteria of the National High Blood Pressure
Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents (95th percentile of the distribution for sex,
age, and height percentile); each line represents a different age in years (10–16), and the labels on the x-axis show the height percentiles for
which the cutoffs were tabulated by the NHBPEP (15). The dashed horizontal lines represent the International Diabetes Federation cutpoints
for systolic BP (130 mm Hg) and diastolic BP (85 mm Hg) (11).
Am J Epidemiol. 2017;185(4):295–303
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To assess the relevance of the classification errors in a
clinical setting, we also assessed the positive predictive
value (PPV) and the negative predictive value (NPV) of
the IDF criteria. PPV was the probability of having HBP
by the reference-standard NHBPEP definition when the
subject was also classified as having HBP by the IDF crite-
ria. Similarly, NPV was the probability of not having HBP
according to the reference-standard NHBPEP definition
when the subject was also classified as not having HBP by
the IDF criteria.
Reconstructed general population
FPFs were calculated on the distributions for SBP and
DBP in each sex, age class, and height percentile as the ratio
between the white area between the two cutoffs (false posi-
tives) and the white area to the left of the NHBPEP cutoff,
as shown for a 14-year-old boy at the 90th percentile for
height in Web Figure 2A. Analogously, as shown for a 10-
year-old girl at the 50th percentile for height (Web
Figure 2B), the FNF was calculated directly on the distribu-
tion of the BP of interest as the ratio between the white area
between the two cutoffs (false negatives) and the white area
to the right of the NHBPEP cutoff (24). The same proce-
dures were performed for SBP and DBP.
The PPV and NPV were calculated from the FPF and
FNF values for each sex, age class, and percentile of height,
assuming a prevalence of HBP ranging from 2% to 30%
and using Bayes’ theorem (24).
Overweight/obese adolescent sample
FNFs were calculated as number of false negatives (i.e.,
number of adolescents incorrectly classified as negative by
IDF criteria) divided by the number of adolescents classi-
fied as having HBP according to the NHBPEP criteria.
FPFs were calculated as the number of false positives (i.e.,
number of adolescents incorrectly classified as positive by
IDF criteria) divided by the number of adolescents classi-
fied as not having HBP according to the NHBPEP criteria.
The NPV was calculated as the number of adolescents clas-
sified as not having HBP according to NHBPEP criteria
divided by the number of adolescents classified as not hav-
ing HBP according to IDF criteria, while the PPV was cal-
culated as the number of children with HBP according to
NHBPEP divided by the number of adolescents classified
as having HBP according to IDF criteria. We also con-
structed receiver operating characteristic curves to evaluate
the use of different fixed BP cutpoints, using NHBPEP as
the reference standard. The receiver operating characteristic
curves were obtained by plotting the true positive fraction
against the FPF, varying the cutoff of choice. For DBP we
let the cutoff vary from 45 mm Hg to 100 mm Hg and for




FNFs for SBP and DBP in boys and girls at different ages
and height percentiles are shown in Figure 2). As an exam-
ple, looking at the line for SBP in male 10-year-olds (in
Figure 2A), the percentage of boys who have HBP ac-
cording to NHBPEP definition and are incorrectly classi-
fied as not having HBP by IDF criteria is 91%. All FNFs
progressively decreased with increasing age and height
percentile (Figure 2A). FNFs were higher among girls than
among boys, especially for SBP with increasing age and at
early ages for DBP. FNFs were also higher in subjects with
a lower height percentile (see Figure 2B). The FPFs (patients
classified as not having HBP by NHBPEP and incorrectly
classified as hypertensive by IDF criteria) were very low.
In fact, FPFs were greater than 0 only for SBP in male 15-
to 16-years-olds. FPFs were present only for subjects at the
highest height percentile.
Figure 3 shows NPVs according to age and sex, obtained
assuming different prevalences (from 2% to 30%) of HBP
in the population and averaging height across percentiles.
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Figure 2. False negative fraction (FNF) in a reconstructed general population. A) systolic and diastolic blood pressure according to age and
sex (averaged across height percentiles); B) FNF for systolic blood pressure in boys according to age and height percentile.
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of 2% (filled circle) and a normotension prevalence of 98%.
We can see that the fraction of 10-year-old boys with normal
systolic BP (according to NHBPEP criteria) in the total num-
ber of subjects classified as normotensive according to IDF cri-
teria is 98% (Figure 3B). Thus, 2% (100% – 98%) of subjects
classified as normotensive by IDF actually have HBP. Let us
observe, however, that 98% is also the overall fraction of nor-
motensive individuals in such a population, and thus 98% is
the NPV that we would obtain if classifying all subjects as nor-
motensive without measuring the BP. Therefore, in this case
the IDF criteria were not useful as a means to exclude HBP.
Let us consider now a population with an HBP prevalence
of 30% (filled square). We can see that the fraction of 14-
year-old boys classified as normotensive by the IDF criteria
among those with normal systolic BP under the NHBPEP
definition is 90% (Figure 3B). In this case, the fraction of
normotensive individuals is 70%, which is the NPV we would
obtain if classifying all subjects as normotensive without mea-
suring the BP. Thus, in this case there is some utility in
excluding HBP. However, 10% of individuals still have HBP
according to the NHBPEP definition and yet are incorrectly
classified as normotensive by IDF criteria.
Overall, for both SBP and DBP, NPVs are low for youn-
ger patients and decrease with increasing prevalence of
HBP, regardless of sex.
Web Table 1 shows the NPVs for prevalence of HBP by
percentile of height in male 10-year-olds (SBP). The para-
meters are the same those for Figure 3. The lowest NPVs
were associated with the lowest height percentiles. PPVs
were obtained for different prevalences of hypertension,
similarly to NPVs. PPVs are not listed because they were
in most cases equal to 100%.
Overweight/obese adolescent sample
The characteristics of the 1,162 participants in the clini-
cal sample are shown in Table 1. Age distribution of parti-
cipants was as follows: 274 subjects aged 10 years, 267
aged 11 years, 245 aged 12 years, 177 aged 13 years, 117
aged 14 years, and 82 aged 15 years. All pubertal stages
were represented: Tanner stage 1 (n = 311); stage 2 (n =
293); stage 3 (n = 219); stage 4 (n = 136); and stage 5
(n = 203). A total of 895 children were classified as obese







































































































Figure 3. Negative predictive values (NPVs) as a percentage for International Diabetes Federation criteria for systolic and diastolic blood
pressure (BP) in a reconstructed general population, according to age and selected prevalences of high BP (from 2% to 30%). A) Systolic BP in
girls; B) systolic BP in boys; C) diastolic BP in girls; D) diastolic BP in boys.
Am J Epidemiol. 2017;185(4):295–303









alavasi user on 28 January 2021
variables and blood pressure were similar in each age class
(data not shown).
The overall prevalence of HBP as defined by NHBPEP
was 32%, and it was slightly higher in girls (34%) than in
boys (30%). Systolic HBP was more frequent than diastolic
HBP (26% vs. 14%). Considering only obese patients (n =
895), the fraction of those who had HBP dropped from 35%
using the NHBPEP criteria to 17% using the IDF cutpoints.
Concerning the comparison between the NHBPEP defini-
tion and the IDF proposal, the observed overall FNF was
22% and the FPF was 2%. FNFs in the study sample were
lower than expected based on analysis of the reconstructed
general population in both sexes for both SBP and DBP: The
highest values were observed in the 10–12 years age classes
(from 16% to 41% for SBP and from 12% to 60% for DBP).
This was to some extent expected given the high prevalence
of excess weight in the study population (25–27).
FNF tended to decrease with increasing age. FPFs were
detectable only in subjects aged 13 years or older and mostly
for systolic BP in boys (from 4% to 35%). NPVs observed
in the clinical study, for age and sex, are shown in Table 2.
NPVs were higher than expected from the analysis of the
reconstructed NHBPEP population, for both SBP and DBP
in both boys and girls.
The receiver operating characteristic curves (Figure 4)
showed that the IDF single cutpoints were not optimal for
the girls in our overweight/obese population (Figure 4A).
Particularly when using a cutpoint of 80 mm Hg for DBP, the
FPF was still less than 1%, but sensitivity rose to 70%, which
is remarkably greater than the 43% at the 85 mm Hg cutpoint.
The same was true for SBP, where a cutpoint of 125 mm Hg
increased the sensitivity from 45% (at the 130 mm Hg cut-
point) to 82% while increasing the FPF only from 0% to 4%.
For boys (Figure 4B), the systolic IDF cutpoint performed bet-
ter, while for DBP a cutpoint of 80 mm Hg increased the sen-
sitivity from 53% to 94% with the FPF still lower than 1%.
DISCUSSION
Our work highlights the potential pitfalls of adopting a sin-
gle BP cutpoint for the whole age range of 10–16 years. Until
recently, elevated blood pressure in children has been defined
worldwide defined according to the 95th percentile for age,
sex, and height percentile (15). At the present time, there are
no outcome data from long-term longitudinal surveys that
Table 2. Negative Predictive Values and Percentage of
Hypertensive Subjects, for Systolic and Diastolic Blood Pressure
According to Gender and Age, Among a Clinical Sample of
Overweight/Obese Adolescents Recruited From Pediatric Centers













10 91 81 20 80
11 92 73 27 73
12 95 85 24 76
13 100 89 20 80
14 97 90 31 69
15 100 95 29 71
Female
10 90 81 25 75
11 88 73 27 73
12 89 75 27 73
13 98 78 30 70
14 95 82 35 65
15 100 86 26 74
Diastolic Blood Pressure
Male
10 98 94 12 88
11 98 94 10 90
12 98 94 13 87
13 99 95 9 91
14 100 91 18 82
15 100 97 11 89
Female
10 88 84 20 80
11 89 85 18 82
12 93 87 23 77
13 100 94 12 88
14 100 96 8 92
15 100 99 6 94
Abbreviation: NPV, negative predictive value.
a Values from the analysis of a reconstructed general population,
based on the distributions tabulated by the National High Blood
Pressure Education Program Working Group on High Blood Pressure
in Children and Adolescents, are reported for comparison (15).
Table 1. Characteristics of Obese/Overweight Adolescents
Recruited From Pediatric Centers (n = 1,162), Italy and Spain,
1998–2000
Variable Median (IQR) Minimum Maximum
Age, years 12 (2) 10 16
Weight, kg 63.6 (18.7) 32.5 122.6
Weight, z score 1.97 (0.77) −0.70 3.74
Height, m 1.54 (0.14) 1.24 1.86
Height, z score 0.70 (1.40) −3.28 4.34
BMIa 26.7 (4.6) 16.9 44.9
BMI, z score 1.93 (0.52) 0.01 2.84
Systolic BP, mm Hg 120 (15) 77 145
Systolic BP, z score 1.03 (1.38) −3.17 3.49
Diastolic BP, mm Hg 70 (15) 45 100
Diastolic BP, z score 0.71 (1.15) −1.63 3.17
Abbreviations: BMI, body mass index; BP, blood pressure; IQR,
interquartile range.
a BMI was calculated as weight (kg)/height (m)2.
Am J Epidemiol. 2017;185(4):295–303
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enable us to identify which BP values at pediatric ages are
associated with health consequences later in life. However,
NHBPEP-defined hypertension has been associated with early
organ damage in several studies (17, 18). In addition, the exis-
tence of tracking from elevated blood pressure in childhood to
hypertension later in life (28, 29), together with the well-
known impact of hypertension on the risk of cardiovascular
events in adults, suggests the presence of a relationship
between elevated blood pressure in childhood and cardiovas-
cular risk in adulthood. Pediatric researchers have derived
age- and sex-specific cutpoints for other MS risk factors (i.e.,
body mass index and lipid parameters) from adult thresholds,
using LMS growth-curve regression methods (30, 31), but
this approach has not yet been reported for BP (32). The IDF
consensus group (12) adopted the same cutpoints used for the
adult MS definition (33) without taking age-related fluctua-
tions into account. This definition has been used in recent lit-
erature (13). By contrast, the established NHBPEP criteria are
based on values ≥95th percentile by age, sex, and height per-
centile. This is a typical complexity encountered in growing
populations, in which developmental changes modify blood
pressure level. However, it must be pointed out that pediatri-
cians are very familiar with the concept of percentiles—for
example, for the assessment of anthropometric measurements,
using growth charts. Consequently, we think that simplified
single-cutpoint criteria, even if easier to use, should be recom-
mended only after a careful evaluation of the potential classifi-
cation errors.
This distributional approach has the advantage of giving
a definition of pre-HBP, as a value of SBP or DBP at or
above the 90th percentile but lower than the 95th percentile
(26, 34). Even weaker conditions, such as transient hyper-
tension/prehypertension in children, have received attention
in the literature of late (26), and recent data have shown a
relationship between hypertension staging and the risk of
left ventricular hypertrophy in adolescents (17, 18).
With an innovative approach, we showed that using the
proposed IDF cutpoints can lead to an elevated percentage
of false negatives, especially in younger subjects; however,
a minimal degree of false positives in older subjects also
has to be taken into account. This is probably due to the
overt conservative quality of the IDF’s proposed strategy,
which does not differ by age. FNFs were higher for SBP
than for DBP and for girls compared with boys. Both FNFs
and FPFs were also affected by the subject’s height, with
increased false negatives in shorter subjects and false posi-
tives in taller ones. In general, NPVs seemed relatively
high only for populations with low HBP prevalence but
reduced in those with increased hypertension prevalence.
However, this could delay the diagnosis of being at risk of
MS as well as the subsequent adoption of preventive non-
pharmacological strategies.
Among the clinical sample, 32% of overweight/obese
subjects had HBP according to NHBPEP definition—a per-
centage similar to previously published data in overweight/
obese adolescents (19, 35, 36). When the IDF criteria were
used, we found a false-negative rate of 22% and a false-
positive rate of 2%. In particular, the proposed single cut-
points of ≥130 mm Hg for SBP and ≥85 mm Hg for DBP
underestimate HBP in children up to 13 years of age and
overestimate HBP in a small proportion of older subjects,
suggesting that the IDF criteria can be used, at most, to
rule in elevated blood pressure. NPVs were higher among
the clinical sample than expected, based on the analysis of
the reconstructed general population, for SBP and DBP in
both sexes. This finding was due to the shift of the BP dis-
tributions toward the higher values found in obese or over-













































Figure 4. Receiver operating characteristic curves for a comparison of high blood pressure (BP) criteria among 1,162 overweight/obese ado-
lescent boys and girls, Italy and Spain, 1998–2000. The criteria of the National High Blood Pressure Education Program Working Group on
High Blood Pressure in Children and Adolescents were the reference standard (15). For diastolic BP (dashed line), we let the cutoff vary from
45 mm Hg (upper right) to 100 mm Hg (lower left), and for systolic BP (solid line) from 70 (upper right) to 150 (lower left). The empty and solid
circles represent the International Diabetes Federation cutoffs for systolic (≥130 mm Hg) and diastolic (≥85 mm Hg) BP.
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independently from the diagnosis of HBP (25). However,
even if they were higher than expected, NPVs were far
from what is needed from an optimal diagnostic tool:
Optimal NPVs (≥95%) were reached only in the 13–15
years age classes.
A limitation of this study is that the clinical sample is
relatively small. The decision to use the reconstructed gen-
eral population was motivated mainly to support, from a
theoretical point of view, the results of the analysis of the
clinical population. However, generalizability to popula-
tions with different ethnic and height distributions cannot
be presumed. We chose an overweight/obese population
because the IDF definition of MS requires abdominal obe-
sity as a mandatory criterion.
We think that an ideal diagnostic tool for HBP should
have a minimal rate of false negatives in order to identify
and treat all subjects at risk, because even mild BP eleva-
tion has been shown to be associated with health conse-
quences in adolescents (37–40). Moreover, there are recent
suggestions that using simplified dichotomized cutoffs for
other criteria used for MS diagnosis actually does miss a
relevant proportion of adolescents with MS (40, 41). We
acknowledge that the percentile method is very cumber-
some to use. However, we feel that the desirable effort to
simplify hypertension diagnosis, as in the spirit of the IDF
proposal, seems to be undermined by the high clinical cost
of undiagnosed HBP in adolescents and the subsequent
lack of adequate management of affected patients.
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